ARCHIVES

In Brief: Override Failure Would Leave Cancer Program With No Money or New Projects Of Any Kind

This article is from The Cancer Letter archive.

Vol. 02 No. 04 | January 23, 1976

Download PDF Visit The Full Archive

Related Articles

Rosenberg Team May Have Cloned Melanoma Gene

May 31, 1991

Afinitor Extends PFS In Women With EGFR-2 Positive Disease

June 28, 2013

Erbitux Plus Chemo Effective For NSCLC; Carboplatin Prevents Testicular Recurrence

July 25, 2008

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

Hughes institute Considers More Support For Genome Mapping

August 1, 1986

NIH Director Varmus Names President of Sloan-Kettering, Succeeding Mark

October 15, 1999